• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征成年人群中患阿尔茨海默病风险的认知早期变化标志物。

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.

作者信息

Aschenbrenner Andrew J, Baksh R Asaad, Benejam Bessy, Beresford-Webb Jessica A, Coppus Antonia, Fortea Juan, Handen Benjamin L, Hartley Sigan, Head Elizabeth, Jaeger Judith, Levin Johannes, Loosli Sandra V, Rebillat Anne-Sophie, Sacco Silvia, Schmitt Frederick A, Thurlow Kate E, Zaman Shahid, Hassenstab Jason, Strydom Andre

机构信息

Washington University in St. Louis, Department of Neurology St. Louis Missouri USA.

Institute of Psychiatry, Psychology, and Neuroscience Department of Forensic and Neurodevelopmental Sciences King's College London London UK.

出版信息

Alzheimers Dement (Amst). 2021 May 2;13(1):e12184. doi: 10.1002/dad2.12184. eCollection 2021.

DOI:10.1002/dad2.12184
PMID:33969175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8088591/
Abstract

INTRODUCTION

Down syndrome (DS), a genetic variant of early onset Alzheimer's disease (AD), lacks a suitable outcome measure for prevention trials targeting pre-dementia stages.

METHODS

We used cognitive test data collected in several longitudinal aging studies internationally from 312 participants with DS without dementia to identify composites that were sensitive to change over time. We then conducted additional analyses to provide support for the utility of the composites. The composites were presented to an expert panel to determine the most optimal cognitive battery based on predetermined criteria.

RESULTS

There were common cognitive domains across site composites, which were sensitive to early decline. The final composite consisted of memory, language/executive functioning, selective attention, orientation, and praxis tests.

DISCUSSION

We have identified a composite that is sensitive to early decline and thus may have utility as an outcome measure in trials to prevent or delay symptoms of AD in DS.

摘要

引言

唐氏综合征(DS)是早发性阿尔茨海默病(AD)的一种基因变异型,针对痴呆前期阶段的预防试验缺乏合适的结局指标。

方法

我们使用了国际上几项纵向衰老研究中收集的认知测试数据,这些数据来自312名无痴呆的DS参与者,以确定对随时间变化敏感的综合指标。然后我们进行了额外的分析,以支持这些综合指标的实用性。将这些综合指标提交给一个专家小组,根据预定标准确定最优化的认知测试组合。

结果

各研究点的综合指标中有共同的认知领域,这些领域对早期衰退敏感。最终的综合指标包括记忆、语言/执行功能、选择性注意、定向和实践测试。

讨论

我们已经确定了一个对早期衰退敏感的综合指标,因此它可能作为一种结局指标用于预防或延缓DS中AD症状的试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e94/8088591/7f95b50a4b8d/DAD2-13-e12184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e94/8088591/f9d4ce135fee/DAD2-13-e12184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e94/8088591/7f95b50a4b8d/DAD2-13-e12184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e94/8088591/f9d4ce135fee/DAD2-13-e12184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e94/8088591/7f95b50a4b8d/DAD2-13-e12184-g001.jpg

相似文献

1
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.唐氏综合征成年人群中患阿尔茨海默病风险的认知早期变化标志物。
Alzheimers Dement (Amst). 2021 May 2;13(1):e12184. doi: 10.1002/dad2.12184. eCollection 2021.
2
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.阿尔茨海默病预防计划综合认知测试:一种用于跟踪临床前阿尔茨海默病认知能力下降的实用方法。
Alzheimers Res Ther. 2020 May 27;12(1):66. doi: 10.1186/s13195-020-00633-2.
3
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study.用于唐氏综合征患者的阿尔茨海默病神经心理测试组合CAMCOG-DS-II的验证:地平线21欧洲唐氏综合征联盟研究
Alzheimers Dement. 2025 Mar;21(3):e70071. doi: 10.1002/alz.70071.
4
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.阿尔茨海默病多基因风险评分与唐氏综合征的认知表型相关。
Alzheimers Dement. 2024 Feb;20(2):1038-1049. doi: 10.1002/alz.13506. Epub 2023 Oct 19.
5
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.阿尔茨海默病预防计划综合认知测试分数:早老素1 E280A突变携带者中用于评估临床前阿尔茨海默病治疗的样本量估计
J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927.
6
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndrome.唐氏综合征中淀粉样蛋白年龄和tau蛋白PET成像至症状性阿尔茨海默病的时间线
medRxiv. 2024 Aug 9:2024.08.08.24311702. doi: 10.1101/2024.08.08.24311702.
7
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.一种基于经验得出的综合认知测试分数,具有更强的能力来跟踪和评估临床前阿尔茨海默病的治疗。
Alzheimers Dement. 2014 Nov;10(6):666-74. doi: 10.1016/j.jalz.2014.02.002. Epub 2014 Apr 21.
8
The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome.唐氏综合征患者在阿尔茨海默病发病前身体活动与CAMDEX-DS变化之间的关联
J Clin Med. 2021 Apr 27;10(9):1882. doi: 10.3390/jcm10091882.
9
Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.唐氏综合征中与阿尔茨海默病相关的衰老性认知变化。
Ann Clin Transl Neurol. 2018 May 20;5(6):741-751. doi: 10.1002/acn3.571. eCollection 2018 Jun.
10
The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome.伦敦唐氏综合征成人认知评估,用于研究唐氏综合征患者的认知能力及衰退情况。
Wellcome Open Res. 2016 Nov 15;1:11. doi: 10.12688/wellcomeopenres.9961.1.

引用本文的文献

1
Staging of Alzheimer's disease progression in Down syndrome using mixed clinical and plasma biomarker measures with machine learning.利用混合临床和血浆生物标志物测量及机器学习对唐氏综合征中阿尔茨海默病进展进行分期
Alzheimers Dement. 2025 Jul;21(7):e70446. doi: 10.1002/alz.70446.
2
Investigating the eye in Down syndrome as a window to Alzheimer's disease: the REVEAL protocol - a clinical cross-sectional study.将唐氏综合征患者的眼睛作为阿尔茨海默病的窗口进行研究:REVEAL方案——一项临床横断面研究。
BMJ Open. 2025 Jul 5;15(7):e098285. doi: 10.1136/bmjopen-2024-098285.
3
Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.

本文引用的文献

1
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests.使用神经心理学测试对唐氏综合征成年患者的前驱期和阿尔茨海默病性痴呆进行诊断。
Alzheimers Dement (Amst). 2020 Jun 28;12(1):e12047. doi: 10.1002/dad2.12047. eCollection 2020.
2
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.唐氏综合征成人阿尔茨海默病的临床和生物标志物变化:一项横断面研究。
Lancet. 2020 Jun 27;395(10242):1988-1997. doi: 10.1016/S0140-6736(20)30689-9.
3
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
基因决定的阿尔茨海默病研究进展:2024年唐氏综合征与常染色体显性阿尔茨海默病会议
Alzheimers Dement. 2025 Jul;21(7):e70309. doi: 10.1002/alz.70309.
4
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.唐氏综合征巴塞罗那神经影像倡议组织(DABNI)及其对理解唐氏综合征中的阿尔茨海默病的贡献:十年探索成果
Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.
5
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year report.阿尔茨海默病生物标志物联盟-唐氏综合征(ABC-DS):一份10年报告。
Alzheimers Dement. 2025 May;21(5):e70294. doi: 10.1002/alz.70294.
6
Behavioral and psychological symptoms of dementia and Alzheimer's disease progression in Down syndrome.唐氏综合征中痴呆和阿尔茨海默病进展的行为和心理症状
J Neurodev Disord. 2025 Apr 11;17(1):19. doi: 10.1186/s11689-025-09604-w.
7
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study.用于唐氏综合征患者的阿尔茨海默病神经心理测试组合CAMCOG-DS-II的验证:地平线21欧洲唐氏综合征联盟研究
Alzheimers Dement. 2025 Mar;21(3):e70071. doi: 10.1002/alz.70071.
8
Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.一次性评估在唐氏综合征成年患者中识别前驱期阿尔茨海默病的有效性。
Alzheimers Dement (Amst). 2025 Feb 11;17(1):e70076. doi: 10.1002/dad2.70076. eCollection 2025 Jan-Mar.
9
Assessing the Relationship of Brain Metabolites to Cortical Thickness and Dementia Symptoms in Adults with Down Syndrome: A Pilot Study.评估唐氏综合征成人脑部代谢物与皮质厚度及痴呆症状之间的关系:一项初步研究。
Brain Sci. 2024 Dec 11;14(12):1241. doi: 10.3390/brainsci14121241.
10
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society.想象、发现、启发:21三体研究协会第四届国际会议论文集
Neuromolecular Med. 2025 Jan 5;27(1):5. doi: 10.1007/s12017-024-08824-y.
唐氏综合征患者血浆生物标志物的动态变化:Aβ42 相对水平随年龄下降,而 NT1 tau 和 NfL 则增加。
Alzheimers Res Ther. 2020 Mar 19;12(1):27. doi: 10.1186/s13195-020-00593-7.
4
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.唐氏综合征中的阿尔茨海默病:预防试验中被忽视的群体。
Alzheimers Dement (N Y). 2018 Dec 13;4:703-713. doi: 10.1016/j.trci.2018.10.006. eCollection 2018.
5
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.唐氏综合征患者临床前和前驱期阿尔茨海默病的认知标志物。
Alzheimers Dement. 2019 Feb;15(2):245-257. doi: 10.1016/j.jalz.2018.08.009. Epub 2018 Nov 28.
6
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.唐氏综合征成人阿尔茨海默病的血浆和脑脊液生物标志物:一项横断面研究。
Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29.
7
Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.唐氏综合征中与阿尔茨海默病相关的衰老性认知变化。
Ann Clin Transl Neurol. 2018 May 20;5(6):741-751. doi: 10.1002/acn3.571. eCollection 2018 Jun.
8
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.爱丁堡共识:为阿尔茨海默病的疾病修饰疗法的出现做准备。
Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.
9
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.唐氏综合征患者痴呆的前瞻性 20 年纵向随访。
J Intellect Disabil Res. 2017 Sep;61(9):843-852. doi: 10.1111/jir.12390. Epub 2017 Jun 29.
10
Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.唐氏综合征患者的脑预测年龄与β淀粉样蛋白沉积及认知衰退有关。
Neurobiol Aging. 2017 Aug;56:41-49. doi: 10.1016/j.neurobiolaging.2017.04.006. Epub 2017 Apr 18.